Serum thyroglobulin antibody levels within or near to the reference range may interfere with thyroglobulin measurement

Biochemia Medica

Volumn 22, Issue 3, 2012, Pages 365-370

  Löcsei, Zoltán ^a   Szabolcs, István ^b   Rácz, Károly ^c   Kovács, Gábor L ^d   Horváth, Dóra ^a   Toldy, Erzsébet ^a,d  

^a Markusovszky Teaching Hospital   (Hungary)

^b NATIONAL MEDICAL CENTER   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Antibody interference; Assay; Thyroglobulin; Thyroglobulin antibodies

Indexed keywords

THYROGLOBULIN; THYROGLOBULIN ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IN VITRO STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; REFERENCE VALUE;

ADULT; AUTOANTIBODIES; BIOLOGICAL ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; THYROGLOBULIN; THYROID NEOPLASMS;

EID: 84867259152     PISSN: 13300962     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-214.
2. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787-803.
3. Spencer CA. Assay of thyroid hormones and related substances. Available at: http://www.mhri.edu.au/biostats/ DAG Stat/. Accessed January 1, 2010.
4. Spencer CA, Lopresti JS. Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer. Nat Clin Pract Endocrinol Metab 2008;4:223-33.
5. Spencer CA. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab 2011;96:3615-27.
6. Spencer C, Petrovic I, Fatemi S. Current thyroglobulin autoantibady (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J Clin Endocrinol Metab 2011;96:1283-91.
7. Rosario PW, Maia FF, Fagundes TA, Vasconcelos FP, Cardoso LD, Purisch S. Antithyroglobulin antibodies in patients with differentiated thyroid carcinoma: methods of detection, interference with serum thyroglobulin measurement and clinical significance. Arq Bras Endocrinol Metab 2004;48:487-92.
8. Gorges R, Maniecki M, Jentzen W, Sheu SN, Mann K, Bockisch A, Janssen OE. Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy. Eur J Endocrinol 2005;153:49-55.
9. Toldy E, Lo{double acute}csei Z, Szabolcs I, Kovács GL. Assay-dependent interference of normal thyroglobulin-antibody levels with thyroglobulin measurement. Clin Chem 2007;Suppl 45:T379.
10. Cubero JM, Rodríguez-Espinosa J, Gelpi C, Estorch M, Corcoy R. Thyroglobulin autoantibody levels below the cutoff for positivity can interfere with thyroglobulin measurement. Thyroid 2003;1:659-61.
11. Krahn J, Dembinski T. Thyroglobulin and anti-thyroglobulin assays in thyroid cancer monitoring. Clin Biochem 2009;42:416-9.
12. Shimizu K, Nakamura K, Kobatake S, Satomura S, Maruyama M, Kameko F, et al. The clinical utility of Lens culinaris agglutinin-reactive thyroglobulin ratio in serum for distinguishing benign from malignant conditions of the thyroid. Clin Chim Acta 2007;379:101-4.